Recent medical research breakthroughs have generated an unprecedented opportunity for potential new therapies—from genetic modifications to novel proteins—to address unmet needs in many medical areas like blindness and paralysis. At the March 19 WHIPgroup Meetup, Erika Smith of New Haven-based ReNetX Bio, will explore the science behind this new generation of biotech advancements and the opportunities for patients, researchers and investors.
Erika Smith is CEO of ReNetX Bio, a biotech firm that has created first in class therapeutics to treat injury/damage to the central nervous system (CNS) in conditions such as spinal cord injury (SCI), stroke and glaucoma. Ms. Smith has spent her career advancing entrepreneurs and investing in tech and biotech innovation. She was previously the Director for the $25 Million USD Blavatnik Fund for Innovation at Yale and was part of the leadership team at Yale Entrepreneurial Institute.
The Gallery WHIPgroup is a collaboration between the Fernando Luis Alvarez Gallery and Whitmyer IP Group in recognition of their joint dedication to celebrate both downtown Stamford and creativity in all its forms. Curated by [Read More…]
WHIPgroup attorneys were successful in overcoming § 101 rejections for a patent application directed to an Intellectual Property (IP) system. The invention relates to an automated network-based system that replicates IP applications between jurisdictions for [Read More…]
WHIPgroup is seeking a new resident for the InventLab™ tech accelerator program located in its Stamford, CT offices. InventLab™ is intended to build upon WHIPgroup’s successful Stamford Tech Entrepreneur Meetup (meetup.com/whipgroup) by offering direct support [Read More…]